ALK is a lineage-restricted oncoprotein expressed on the cell surface of NBL as wild-type (WT), mutated, or amplified kinase, and recently shown to be overexpressed in fusion-positive rhabdomyosarcoma (RMS) [36]. This evidence concerns the gene ALK and rhabdomyosarcoma.